Fintepla TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: fenfluramine
Brand name
(ARTG)
: FINTEPLA fenfluramine 2.2 mg/mL Oral Solution BottleConsumer Medicine Information (CMI)
Read the CMI leaflet for facts you need to know before, during and after taking your medicine.
For more information about CMIs and how to read them, please visit How to read Consumer Medicine Information (CMI).
What this medicine is used for
(ARTG)
Fintepla is indicated as add-on therapy in the treatment of seizures associated with Dravet syndrome (DS) and Lennox-Gastaut syndrome (LGS) in patients 2 years of age and older.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Oral Liquid, solution
- Oral
- The solution is a clear, colourless, slightly viscous liquid
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- Do not Freeze
- Do not Refrigerate
- Shelf lifetime is 4 Years.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 60mL, 120mL, 250mL, 360mL pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient fenfluramine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
- You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems.
- For more information on the Black Triangle Scheme and how to report side effects, see www.tga.gov.au/black-triangle-scheme
